Reactive arthritis / Reiter’s syndrome

Check out my separate entry under Spondyloarthritis

Summary

Under Investigation

Symptoms

Under Investigation

Diagnostic Criteria

None. (Aggarwal et al, 2015)

Study Classification Criteria

Under Investigation

Diagnostic Tests

Under Investigation

Organized Autoimmunity

(Alternative Autoimmune Disease Classification: FIEM, MIEM or BIEM, or FEM, MEM or BEM)

1. sex predominance (is an autoimmune disease primarily found in genetic Females, Males, or equally in Both?)

   1. Under Investigation

2. Inherited and acquired gene variations that cause increased susceptibility

   1. Human Leukocyte Antigen (HLA) Associations

      1. Under Investigation

   2. Other Gene Variations (mutations)

      1. Under Investigation

3. Gene Triggering Environmental Exposures

   1. Infections

      1. COVID-19 (Metyas et. al, 2022 documented one case of Reactive arthritis two days after COVID-19 diagnosis)

   2. Toxins

      1. Under Investigation

   3. Stress

      1. Needs to be assessed for each patient

4. Multiple interactive and destructive immune system pathologies

   1. Under Investigation

Tissue-Type or Cell-Type Attacked

Under Investigation

Treatment(s)

Under Investigation

Managing Specialist(s)

Under Investigation

Research Authors

Under Investigation

Research Institutions

Under Investigation

Average Time from Symptom Onset to Diagnosis

Under Investigation

Last Updated

July 06, 2023

References

Metyas S, Chen C, Aung T, Ballester A, Cheav S. Rheumatologic Manifestations of Post SARS-CoV-2 Infection: A Case Series. Curr Rheumatol Rev. 2022;18(4):346-351. doi: 10.2174/1573397118666220211155716. PMID: 35152867.